DelveInsight's 'Antisense Oligonucleotide Therapeutics Pipeline Insight 2025' report provides comprehensive global coverage of pipeline antisense oligonucleotide therapeutics in various stages of ...
Scientists at St. Jude Children's Research Hospital have found that they can reverse the effects of HNRNPH2-related neurodevelopmental disorder using antisense oligonucleotides (ASOs) in preclinical ...
Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Antisense Oligonucleotides Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Antisense Molecule, Type of ASO Generation, ...
A biophysics-informed machine learning framework predicts how effectively antisense oligonucleotides knock down ALS-relevant ...
Nucleic acid therapeutics, such as antisense oligonucleotides (ASOs), have emerged as promising platforms for treating a ...
Antisense oligonucleotides (ASOs) have been proposed as a therapeutic approach to shut down the production of faulty proteins in a wide variety of diseases, including cancer. In a study published in ...
A new review maps how artificial intelligence is transforming RNA-targeted drug discovery across both small molecules and ...
PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples to train ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results